Selectis Health, Inc.
GBCS · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.10 | -0.16 | 0.02 |
| FCF Yield | 9.20% | -3.57% | 12.10% | -12.61% |
| EV / EBITDA | -25.48 | 134.65 | 150.22 | 131.79 |
| Quality | ||||
| ROIC | -2.16% | -1.79% | -1.62% | -0.36% |
| Gross Margin | 0.00% | 21.89% | 22.94% | 24.34% |
| Cash Conversion Ratio | 0.37 | 0.25 | -1.58 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.04% | 4.11% | 2.20% | 0.71% |
| Free Cash Flow Growth | 375.13% | -129.52% | 288.41% | 64.70% |
| Safety | ||||
| Net Debt / EBITDA | -1.21 | 110.61 | 123.20 | 118.85 |
| Interest Coverage | 1.44 | -1.99 | -0.78 | -0.27 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 26.52 | -61.50 | -65.55 | -52.56 |